Showing results (1451-1460 of 1,566) with videos related to

Sort By:
Pageof 157
Oncogene|August 28, 2020
HPV E2, E4, E5 drive alternative carcinogenic pathways in HPV positive cancersShuling Ren, Daria A Gaykalova, Theresa Guo, et al.
Journal of Robotic Surgery|May 7, 2025
Costs of robot-assisted vs. open approaches for 5 major cancersFrancesco Di Bello, Natali Rodriguez Peñaranda, Andrea Marmiroli, et al.
Nature Communications|February 12, 2019
Hectd3 promotes pathogenic Th17 lineage through Stat3 activation and Malt1 signaling in neuroinflammationJonathan J Cho, Zhiwei Xu, Upasana Parthasarathy, et al.
Clinical Lung Cancer|August 29, 2022
Efficacy and Safety of Brigatinib Compared With Crizotinib in Asian vs. Non-Asian Patients With Locally Advanced or Metastatic ALK-Inhibitor-Naive ALK+ Non-Small Cell Lung Cancer: Final Results From the Phase III ALTA-1L StudyMyung J Ahn, Hye R Kim, James C H Yang, et al.
Nature Communications|May 18, 2019
Chromatin dysregulation and DNA methylation at transcription start sites associated with transcriptional repression in cancersMizuo Ando, Yuki Saito, Guorong Xu, et al.
Nature Communications|September 21, 2018
Differentiation-state plasticity is a targetable resistance mechanism in basal-like breast cancerTyler Risom, Ellen M Langer, Margaret P Chapman, et al.
JCO Clinical Cancer Informatics|April 18, 2023
Experience With the Routine Use of Electronic Patient-Reported Outcome Measures for Patients With Lung CancerCathryn Crockett, James Price, Mai Pham, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 12, 2020
Brigatinib Versus Crizotinib in Advanced ALK Inhibitor-Naive ALK-Positive Non-Small Cell Lung Cancer: Second Interim Analysis of the Phase III ALTA-1L TrialD Ross Camidge, Hye Ryun Kim, Myung-Ju Ahn, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 24, 2025
Brief Report: Post Hoc Validation of Platinum Ineligibility in NSCLC From the Phase III IPSOS StudySolange Peters, Christian Schulz, Martin Reck, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|July 5, 2024
Survival of stage III non-seminoma testis cancer patients versus simulated controls, according to race/ethnicitySimone Morra, Cristina Cano Garcia, Mattia Luca Piccinelli, et al.
Pageof 157